182493230
liked
$Micron Technology (MU.US)$
After the earnings reports, it skyrocketed in after-hours trading.
Semiconductor industry earnings are still strong.
Vroom ← Article
After the earnings reports, it skyrocketed in after-hours trading.
Semiconductor industry earnings are still strong.
Vroom ← Article
Translated
4
2
182493230
liked and commented on
Amgen has been on a downward trend for a while. If you get out of here, you'll go up there, right? It would be nice if there was a function that would let you know 🔔 when you break through this trend line.
Translated
1
3
2
182493230
reacted to and commented on
182493230
commented on
3/21 is the super trend of futures.
I will switch to Buy at 40338 yen, but in the morning, it's a close battle to keep above this level, and as of 9:30, it's been repeatedly switching between Buy and Sell. However, this is also a closing price judgment, so let's see if it can hold above 40338 yen by 15:15 today.
If the Bank of Japan and FOMC return to Buy after passing, it will continue the long-term uptrend, and the recent decline will be considered a pullback.
I will switch to Buy at 40338 yen, but in the morning, it's a close battle to keep above this level, and as of 9:30, it's been repeatedly switching between Buy and Sell. However, this is also a closing price judgment, so let's see if it can hold above 40338 yen by 15:15 today.
If the Bank of Japan and FOMC return to Buy after passing, it will continue the long-term uptrend, and the recent decline will be considered a pullback.
Translated
4
1
182493230
liked
$Direxion Daily Semiconductor Bear 3x Shares ETF (SOXS.US)$
Semiconductors are too strong.
What should I do?
Semiconductors are too strong.
What should I do?
Translated
3
1
182493230
liked and commented on
The forecast value is about 146.90. The mid-value is around 146.81.
Although it may not be detailed enough, I think the movement of the image I drew is close to the financial estimates. One of the strategies is to consider how to assume the range until the mid-value. If I say it too confidently, I will receive a severe backlash, so I won't say it... In other words, if you're so great, why don't you enter the market? But the truth is, I was just watching because I was afraid. After all, I'm being monitored. For example, even if the market is rising, if I enter, it tends to go down. It's normal, but I'm convinced it's definitely strange. How much am I losing in fx...
Although it may not be detailed enough, I think the movement of the image I drew is close to the financial estimates. One of the strategies is to consider how to assume the range until the mid-value. If I say it too confidently, I will receive a severe backlash, so I won't say it... In other words, if you're so great, why don't you enter the market? But the truth is, I was just watching because I was afraid. After all, I'm being monitored. For example, even if the market is rising, if I enter, it tends to go down. It's normal, but I'm convinced it's definitely strange. How much am I losing in fx...
Translated
3
1
182493230
liked and commented on
$Novo-Nordisk A/S (NVO.US)$ $Eli Lilly and Co (LLY.US)$
Wall Street analysts continue to raise their revenue expectations for Eli Lilly's obesity treatment drug, while more companies are preparing to compete for the Zepbound throne.
Lilly and its competitor Novo Nordisk will dominate the field of obesity treatment drugs with high efficacy, and are likely to continue to do so in the future. However, as other competing drugs begin to emerge from the lab and enter the market, there may also be some that could challenge Zepbound and Novo's Wegovy.
The profitability of weight loss drugs has intensified competition.
Wall Street analysts continue to raise their revenue expectations for Eli Lilly's obesity treatment drug, while more companies are preparing to compete for the Zepbound throne.
Lilly and its competitor Novo Nordisk will dominate the field of obesity treatment drugs with high efficacy, and are likely to continue to do so in the future. However, as other competing drugs begin to emerge from the lab and enter the market, there may also be some that could challenge Zepbound and Novo's Wegovy.
The profitability of weight loss drugs has intensified competition.
Translated
4
1
182493230
commented on
182493230
liked
This is a really earnest wish
It's decided that if you have money to live without losing just by listening, it's better not to lose it
That's the basis of financial inclusion
There are also many strange scams, and there are also people who try to make money by using photos of famous people in advertisements without permission
There are also people who don't mind boating and trying to get money
Please check carefully!
It's decided that if you have money to live without losing just by listening, it's better not to lose it
That's the basis of financial inclusion
There are also many strange scams, and there are also people who try to make money by using photos of famous people in advertisements without permission
There are also people who don't mind boating and trying to get money
Please check carefully!
Translated
9